Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin’s lymphoma: results of the FAB/LMB 96 international study-Reference-Cited by-同舟云学术

Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin’s lymphoma: results of the FAB/LMB 96 international study

Published:2008-06 Issue:6 Volume:141 Page:840-847
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Gerrard Mary,Cairo Mitchell S.,Weston Claire,Auperin Anne,Pinkerton Ross,Lambilliote Anne,Sposto Richard,McCarthy Keith,Lacombe Marie-José T.,Perkins Sherrie L.,Patte Catherine,

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2008.07144.x/fullpdf

Reference33 articles.

1. Childhood Non-Hodgkin's Lymphoma

2. Long-term follow-up of patients treated with COMP or LSA2L2 therapy for childhood non-Hodgkin's lymphoma: a report of CCG-551 from the Childrens Cancer Group.

3. Localized non-Hodgkin's lymphoma with B-cell histology: cure without cyclophosphamide? A report of the United Kingdom Children's Cancer Study Group on studies NHL 8501 and NHL 9001 (1985-1996)

4. Childhood and adolescent non-Hodgkin lymphoma: New insights in biology and critical challenges for the future

5. Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents

Cited by 162 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of body mass index on the prognosis of children and adolescents with high‐grade mature B‐cell non‐Hodgkin lymphoma;Cancer;2024-08-22

2. Large B‐cell lymphoma with mystery rearrangement: Applying Hi‐C to the detection of clinically relevant structural abnormalities;British Journal of Haematology;2024-06-25

3. Rituximab-combined anthracycline-free chemotherapy in newly diagnosed paediatric and adolescent patients with non-high-risk aggressive mature B cell lymphoma: protocol for a single-arm, open-label, multicentre, phase II study (the Japan Children’s Cancer Group Multicentre Trial, JPLSG B-NHL-20);BMJ Open;2024-03

4. Rituximab with standard LMB chemotherapy in pediatric high‐risk mature B‐cell non‐Hodgkin lymphoma: A report from the JPLSG B‐NHL14 trial;European Journal of Haematology;2023-12-19

5. Mature B‐cell lymphomas in adolescents and young adults;eJHaem;2023-09-08